Gilead Issues A Voluntary Recall Of One Lot Of Vistide® (CIDOFOVIR INJECTION) Due To Presence Of Particulate Matter
Posted Feb 15 2013 9:25pm
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is voluntarily recalling lot B120217A of Vistide® (cidofovir injection) to the user level due to the presence of particulate matter found in some vials of this lot.